De Gregorio Miguel A, Guirola Jose A, Lahuerta Celia, Serrano Carolina, Figueredo Ana L, Kuo William T
Miguel A De Gregorio, CIBER BBN - Bioengeering, Biomaterials and Nanomedicine [CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Centro de Investigación Biomédica en Red] C/Monforte de Lemos 3-5, 28029 Madrid, Spain.
World J Radiol. 2017 Jul 28;9(7):295-303. doi: 10.4329/wjr.v9.i7.295.
Venous thromboembolism (VTE) is an illness that has a potentially life-threatening condition that affects a large percentage of the global population. VTE with pulmonary embolism (PE) is the third leading cause of death after myocardial infarction and stroke. In the first three months after an acute PE, there is an estimated 15% mortality among submassive PE, and 68% mortality in massive PE. Current guidelines suggest fibrinolytic therapy regarding the clinical severity, however some studies suggest a more aggressive treatment approach. This review will summarize the available endovascular treatments and the different techniques with its indications and outcomes.
静脉血栓栓塞症(VTE)是一种可能危及生命的疾病,影响着全球很大一部分人口。伴有肺栓塞(PE)的VTE是继心肌梗死和中风之后的第三大死因。在急性PE后的前三个月,亚大块PE的死亡率估计为15%,大块PE的死亡率为68%。目前的指南根据临床严重程度建议采用纤维蛋白溶解疗法,然而一些研究建议采用更积极的治疗方法。本综述将总结现有的血管内治疗方法以及不同技术及其适应证和治疗效果。